Healthcare services, life sciences and pharmaceuticals continue to attract substantial investment from strategic trade players and private equity enticed by innovative, technology-driven assets, the rising healthcare costs, and recurring revenue streams. Despite high levels of M&A activity in recent years and the emergence of large corporate consolidators, the sector remains largely fragmented

Using our sector experience, Provantage can support shareholders and management teams in developing a strategy that positions the business to unlock growth and maximise value.  Provantage has extensive experience in the sector advising on transactions within life sciences, care services, medical devices and medical packaging and consumables